Dossier
A3P Biomedical
Coverage of A3P Biomedical in the Nexus archive.
- New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test called Stockholm3 detects 90% of aggressive prostate cancer cases, outperforming the traditional PSA test which detects 74%. A study involving 12,000 men found Stockholm3 missed significantly fewer serious cases without increasing unnecessary follow-ups.